Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 823-861 , November 2005

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Children: An Evidence-Based Review

  • Theresa Hahn

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • Corresponding Author InformationCorrespondence and reprint requests: Theresa Hahn, PhD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263
    • ,
  • Donna Wall

      Affiliations

    • Texas Transplant Institute, San Antonio, Texas
    • ,
  • Bruce Camitta

      Affiliations

    • Midwest Children’s Center, Medical College of Wisconsin and Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Stella Davies

      Affiliations

    • Cincinnati Children’s Hospital and Medical Center, Cincinnati, Ohio
    • ,
  • Hildy Dillon

      Affiliations

    • The Leukemia and Lymphoma Society, White Plains, New York
    • ,
  • Paul Gaynon

      Affiliations

    • Children’s Hospital of Los Angeles, Los Angeles, California
    • ,
  • Richard A. Larson

      Affiliations

    • University of Chicago, Chicago, Illinois
    • ,
  • Susan Parsons

      Affiliations

    • Dana-Farber Cancer Institute/Harvard Medical School and Tufts New England Medical Center/Tufts University, Boston, Massachusetts
    • ,
  • Jerome Seidenfeld

      Affiliations

    • Blue Cross and Blue Shield Association Technology Evaluation Center, Chicago, Illinois
    • ,
  • Daniel Weisdorf

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota
    • ,
  • Philip L. McCarthy Jr

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York

Received 10 August 2005 ,Accepted 10 August 2005.

References 

  1. Hahn T , Wolff SN , Czuczman MC , et al.   The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma (an evidence-based review) . Biol Blood Marrow Transplant . 2001;7:308–331
  2. Hahn T , Wingard J , Anderson K , et al.   The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma (an evidence-based review) . Biol Blood Marrow Transplant . 2003;9:4–37
  3. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant. In press.
  4. Jones R , Nieto Y , Rizzo JD , et al.   The evolution of the evidence-based review (evaluating the science enhances the art of medicine.—Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation) . Biol Blood Marrow Transplant . 2005;11:819–822
  5. Wheeler KA , Richards SM , Bailey CC , et al.   Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission (results from Medical Research Council UKALL X and XI) . Blood . 2000;96:2412–2418
  6. Chessells JM , Bailey C , Wheeler K , Richards SM . Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission (experience in MRC UKALL X) . Lancet . 1992;340:565–568
  7. Arico M , Valsecchi MG , Camitta B , et al.   Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia . N Engl J Med . 2000;342:998–1006
  8. Uderzo C , Valsecchi MG , Balduzzi A , et al.   Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) . Br J Haematol . 1997;96:387–394
  9. Saarinen UM , Mellander L , Nysom K , et al.   Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia (a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO)) . Bone Marrow Transplant . 1996;17:357–363
  10. Sharathkumar A , Saunders EF , Dror Y , et al.   Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia . Bone Marrow Transplant . 2004;33:39–45
  11. Barrett AJ , Horowitz MM , Pollock BH , et al.   Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission . N Engl J Med . 1994;331:1253–1258
  12. Wheeler K , Richards S , Bailey C , Chessells J . Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia (the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia) . Br J Haematol . 1998;101:94–103
  13. Uderzo C , Valsecchi MG , Bacigalupo A , et al.   Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy (ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association) . J Clin Oncol . 1995;13:352–358
  14. Harrison G , Richards S , Lawson S , et al.   Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party . Ann Oncol . 2000;11:999–1006
  15. Schroeder H , Gustafsson G , Saarinen-Pihkala UM , et al.   Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia (a population-based case control study from the Nordic countries) . Bone Marrow Transplant . 1999;23:555–560
  16. BFM Relapse Study Group Borgmann A , Hartmann R , Schmid H , et al.   Isolated extramedullary relapse in children with acute lymphoblastic leukemia (a comparison between treatment results of chemotherapy and bone marrow transplantation) . Bone Marrow Transplant . 1995;15:515–521
  17. Borgmann A , von Stackelberg A , Hartmann R , et al.   Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission (a matched pair analysis) . Blood . 2003;101:3835–3839
  18. Hoogerbrugge PM , Gerritsen EJ , vd Does-van den Berg A , et al.   Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children . Bone Marrow Transplant . 1995;15:255–259
  19. The Berlin-Frankfurt-Munster Study Group Borgmann A , Schmid H , Hartmann R , et al.   Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission (a matched-pair analysis) . Lancet . 1995;346:873–876
  20. AIEOP/FONOP-TMO group Associzione Italiana Emato-Oncologia Pediatrica Messina C , Valsecchi MG , Arico M , et al.   Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia . Bone Marrow Transplant . 1998;21:9–14
  21. Boulad F , Steinherz P , Reyes B , et al.   Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission (a single-institution study) . J Clin Oncol . 1999;17:197–207
  22. Feig SA , Harris RE , Sather HN . Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia (a study of the Children’s Cancer Group (CCG-1884)) . Med Pediatr Oncol . 1997;29:534–540
  23. Torres A , Martinez F , Gomez P , et al.   Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission . Bone Marrow Transplant . 1989;4:609–612
  24. Johnson FL , Thomas ED , Clark BS , Chard RL , Hartmann JR , Storb R . A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission . N Engl J Med . 1981;305:846–851
  25. Bacigalupo A , Van Lint MT , Frassoni F , et al.   Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission . Bone Marrow Transplant . 1986;1:75–80
  26. AIEOP/FONOP-TMO Group Italian Association of Paediatric Haemato-Oncology Messina C , Cesaro S , Rondelli R , et al.   Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy . Bone Marrow Transplant . 1998;21:1015–1021
  27. Maldonado MS , Diaz-Heredia C , Badell I , et al.   Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission. Spanish Working Party for BMT in Children . Bone Marrow Transplant . 1998;22:1043–1047
  28. Billett AL , Kornmehl E , Tarbell NJ , et al.   Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia . Blood . 1993;81:1651–1657
  29. Sallan SE , Niemeyer CM , Billett AL , et al.   Autologous bone marrow transplantation for acute lymphoblastic leukemia . J Clin Oncol . 1989;7:1594–1601
  30. Colleselli P , Rossetti F , Messina C , et al.   Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission (first choice for isolated extramedullary relapse?) . Bone Marrow Transplant . 1994;14:821–825
  31. Canals C , Torrico C , Picon M , et al.   Immunomagnetic bone marrow purging in children with acute lymphoblastic leukemia . J Hematother . 1997;6:261–268
  32. Lonnerholm G , Simonsson B , Arvidson J , et al.   Autologous bone marrow transplantation in children with acute lymphoblastic leukemia . Acta Paediatr . 1992;81:1017–1022
  33. Houtenbos I , Bracho F , Davenport V , et al.   Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia (a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)) . Bone Marrow Transplant . 2001;27:145–153
  34. Pico JL , Hartmann O , Maraninchi D , et al.   Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemia . J Natl Cancer Inst . 1986;76:1289–1293
  35. Ramsay N , LeBien T , Nesbit M , et al.   Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission (results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement) . Blood . 1985;66:508–513
  36. Schmid H , Henze G , Schwerdtfeger R , et al.   Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia . Bone Marrow Transplant . 1993;12:597–602
  37. Rossetti F , Messina C , Miniero R , et al.   ABMT for early isolated extramedullary relapse of childhood ALL . Bone Marrow Transplant . 1993;12:37–41
  38. Balduzzi A , Gaipa G , Bonanomi S , et al.   Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission (evidence for long-term clinical and molecular remissions) . Leukemia . 2001;15:50–56
  39. Grañena A , Castellsague X , Badell I , et al.   Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia (clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement) . Bone Marrow Transplant . 1999;24:621–627
  40. Garcia J , Punti C , Picon M , et al.   Bone marrow purging in acute lymphoblastic leukemia (biological and clinical features) . J Hematother . 1994;3:203–211
  41. Barrett AJ , Horowitz MM , Gale RP , et al.   Marrow transplantation for acute lymphoblastic leukemia (factors affecting relapse and survival) . Blood . 1989;74:862–871
  42. Weyman C , Graham-Pole J , Emerson S , et al.   Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia (a multicenter survey) . Bone Marrow Transplant . 1993;11:43–50
  43. Borgmann A , Baumgarten E , Schmid H , et al.   Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission (a conceivable alternative?) . Bone Marrow Transplant . 1997;20:939–944
  44. Gustafsson Jernberg Å , Remberger M , Ringdén O , Winiarski J . Graft-versus-leukemia effect in children (chronic GVHD has a significant impact on relapse and survival) . Bone Marrow Transplant . 2003;31:175–181
  45. Brochstein JA , Kernan NA , Groshen S , et al.   Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia . N Engl J Med . 1987;317:1618–1624
  46. Zecca M , Pession A , Messina C , et al.   Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings . J Clin Oncol . 1999;17:1838–1846
  47. Jamieson CHM , Amylon MD , Wong RM , Blume KG . Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide (a 15-year experience) . Exp Hematol . 2003;31:981–986
  48. von Bueltzingsloewen A , Esperou-Bourdeau H , Souillet G , et al.   Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia (a Cooperative Study of the Societe; Francaise de Greffe de Moelle) . Bone Marrow Transplant . 1995;16:521–527
  49. Buchanan GR , Rivera GK , Pollock BH , et al.   Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission (a Pediatric Oncology Group Study) . Cancer . 2000;88:1166–1174
  50. Gordon BG , Warkentin PI , Strandjord SE , et al.   Allogeneic bone marrow transplantation for children with acute leukemia (long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation) . Bone Marrow Transplant . 1997;20:5–10
  51. Sanders JE , Thomas ED , Buckner CD , Doney K . Marrow transplantation for children with acute lymphoblastic leukemia in second remission . Blood . 1987;70:324–326
  52. Shah AJ , Lenarsky C , Kapoor N , et al.   Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation . J Pediatr Hematol Oncol . 2004;26:91–97
  53. Moussalem M , Esperou Bourdeau H , Devergie A , et al.   Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission (factors predictive of survival, relapse and graft-versus-host disease) . Bone Marrow Transplant . 1995;15:943–947
  54. Bordigoni P , Vernant JP , Souillet G , et al.   Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission (a cooperative study of the Groupe d’Etude de la Greffe de Moelle Osseuse) . J Clin Oncol . 1989;7:747–753
  55. Coccia PF , Strandjord SE , Warkentin PI , et al.   High-dose cytosine arabinoside and fractionated total-body irradiation (an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission) . Blood . 1988;71:888–893
  56. Wingard JR , Piantadosi S , Santos GW , et al.   Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia . J Clin Oncol . 1990;8:820–830
  57. Fleming DR , Henslee-Downey PJ , Romond EH , et al.   Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults (a comparative matched cohort study) . Bone Marrow Transplant . 1996;17:917–922
  58. Green A , Clarke E , Hunt L , et al.   Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome . Blood . 1999;94:2236–2246
  59. Oakhill A , Pamphilon DH , Potter MN , et al.   Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission . Br J Haematol . 1996;94:574–578
  60. Bunin N , Carston M , Wall D , et al.   Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission . Blood . 2002;99:3151–3157
  61. Balduzzi A , Gooley T , Anasetti C , et al.   Unrelated donor marrow transplantation in children . Blood . 1995;86:3247–3256
  62. Davies SM , Wagner JE , Shu XO , et al.   Unrelated donor bone marrow transplantation for children with acute leukemia . J Clin Oncol . 1997;15:557–565
  63. Lang P , Handgretinger R , Niethammer D , et al.   Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia . Blood . 2003;101:1630–1636
  64. Marks DI , Bird JM , Cornish JM , et al.   Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia . J Clin Oncol . 1998;16:931–936
  65. Dini G , Grazia Valsecchi M , Micalizzi C , et al.   Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission . Bone Marrow Transplant . 2003;32:325–331
  66. Lausen BF , Heilmann C , Vindelov L , Jacobsen N . Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts . Bone Marrow Transplant . 1998;22:325–330
  67. Saarinen-Pihkala UM , Gustafsson G , Carlsen N , et al.   Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL) (Nordic results on an intensive regimen with restricted central nervous system irradiation) . Pediatr Blood Cancer . 2004;42:8–23
  68. Saarinen-Pihkala UM , Gustafsson G , Ringden O , et al.   No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission . J Clin Oncol . 2001;19:3406–3414
  69. Bunin N , Aplenc R , Kamani N , Shaw K , Cnaan A , Simms S . Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia (a Pediatric Blood and Marrow Transplant Consortium study) . Bone Marrow Transplant . 2003;32:543–548
  70. Davies SM , Ramsay NK , Klein JP , et al.   Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia . J Clin Oncol . 2000;18:340–347
  71. Weisdorf DJ , Woods WG , Nesbit ME , et al.   Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia (risk factors and clinical outcome) . Br J Haematol . 1994;86:62–69
  72. Carpenter PA , Marshall GM , Giri N , Vowels MR , Russell SJ . Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan . Bone Marrow Transplant . 1996;18:489–494
  73. Granados E , de La Camara R , Madero L , et al.   Hematopoietic cell transplantation in acute lymphoblastic leukemia (better long term event-free survival with conditioning regimens containing total body irradiation) . Haematologica . 2000;85:1060–1067
  74. Weisdorf DJ , Billett AL , Hannan P , et al.   Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia . Blood . 1997;90:2962–2968
  75. Uderzo C , Rondelli R , Dini G , et al.   High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission (a 7-year Italian multicentre study) . Br J Haematol . 1995;89:790–797
  76. Parsons SK , Castellino SM , Lehmann LE , et al.   Relapsed acute lymphoblastic leukemia (similar outcomes for autologous and allogeneic marrow transplantation in selected children) . Bone Marrow Transplant . 1996;17:763–768
  77. Lawson SE , Harrison G , Richards S , et al.   The UK experience in treating relapsed childhood acute lymphoblastic leukaemia (a report on the medical research council UKALLR1 study) . Br J Haematol . 2000;108:531–543
  78. Giona F , Testi AM , Rondelli R , et al.   ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse . Br J Haematol . 1997;99:671–677
  79. Testi AM , Moleti ML , Giona F , et al.   Treatment of primary refractory or relapsed acute lymphoblastic leukemia (ALL) in children . Ann Oncol . 1992;3:765–767
  80. Giona F , Testi AM , Annino L , et al.   Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults (the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica) . Br J Haematol . 1994;86:55–61
  81. AIEOP and GIMEMA Cooperative Groups Giona F , Annino L , Testi AM , et al.   Management of advanced acute lymphoblastic leukemia in children and adults (results of the ALL R-87 protocol) . Leuk Lymphoma . 1998;32:89–95
  82. Ringden O , Labopin M , Gluckman E , et al.   Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling?. A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) study . Bone Marrow Transplant . 1997;19:963–968
  83. Woods WG , Ramsay NKC , Weisdorf DJ , et al.   Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside (lack of superiority over cyclophosphamide-containing conditioning regimens) . Bone Marrow Transplant . 1990;6:9–16
  84. Bostrom B , Weisdorf DJ , Kim T , Kersey JH , Ramsay NK . Bone marrow transplantation for advanced acute leukemia (a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide) . Bone Marrow Transplant . 1990;5:83–89
  85. Rheingold SR , Bunin NJ , Aplenc R , Leahey AM , Lange B . Long term survival using intensive multiagent chemotherapy for relapses of pediatric acute lymphoblastic leukemia (ALL) . [abstract] Blood . 2004;104:539a
  86. Jacobsohn DA , Hewlett B , Morgan E , Duerst RE , Kletzel M . Favorable outcome for infant ALL following hematopoietic stem cell transplantation (HSCT) . [abstract] Blood . 2004;104:592a
  87. Locatelli F , Zecca M , Pession A , et al.   Outcome of children with ALL given HSCT from unrelated volunteers has significantly improved over time and now is comparable to that of children transplanted from an HLA-identical sibling . [abstract] Blood . 2004;104:593a
  88. Gharib MI , Greenfield HM , Wynn RF , et al.   Alemtuzumab (Campath 1H) in conditioning therapy with cyclophosphamide and total body irradiation in matched and mismatched unrelated donor transplantation of children with acute lymphoblastic leukemia (a report from 3 U.K. centres) . [abstract] Blood . 2004;104:593a
  89. Watanabe A , Katano N , Kikuta A , et al.   Strategy of cumulative dose reduction of drugs with late effects, using escalating dose of anti-metabolites with or without mega-dose chemotherapy plus autologous peripheral blood stem cell rescue for treatment of childhood acute lymphoblastic leukemia (Children’s Cancer and Leukemia Study Group of Japan (CCSLG), CCLSG ALL 941 Protocol Study) . Blood . 2003;102:223a; [abstr]
  90. Eapen M , Horowitz MM , Klein JP , et al.   Comparable long-term survival after unrelated donor bone marrow or umbilical cord blood and HLA-identical sibling transplants for treatment of acute leukemia in infants . [abstract] Blood . 2003;102:245a
  91. Lang PJ , Greil J , Bader P , et al.   Haploidentical transplantation in pediatric patients with ALL (a comparison with unmanipulated grafts) . [abstract] Blood . 2003;102:486a
  92. National Cancer Policy Board . Childhood Cancer Survivorship (Improving Care and Quality of Life) . Washington, DC: National Academies Press; 2003;

 All terms abbreviated in this article are defined in a Glossary of Terms, Appendix A, at the end of the article.

PII: S1083-8791(05)00567-7

doi: 10.1016/j.bbmt.2005.08.035

Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 823-861 , November 2005

Article Tools

* Image Usage & Resolution